{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:35:34Z","timestamp":1786736134777,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Neurosci"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jpn.jpn_2_19","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T03:23:37Z","timestamp":1566185017000},"page":"100","source":"Crossref","is-referenced-by-count":14,"title":["Mild phenotype associated with SLC6A1 gene mutation: A case report with literature review"],"prefix":"10.4103","volume":"14","author":[{"given":"Annio","family":"Posar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Visconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1817-1745.264744-1","doi-asserted-by":"crossref","unstructured":"Trevelyan AJ, Schevon CA How inhibition influences seizure propagation. Neuropharmacology 2013;69:45-54.","DOI":"10.1016\/j.neuropharm.2012.06.015"},{"key":"key-10.4103\/1817-1745.264744-2","doi-asserted-by":"crossref","unstructured":"Zafar S, Jabeen I Structure, function, and modulation of \u03b3-aminobutyric acid transporter 1 (GAT1) in neurological disorders: A pharmacoinformatic prospective. Front Chem 2018;6:397.","DOI":"10.3389\/fchem.2018.00397"},{"key":"key-10.4103\/1817-1745.264744-3","doi-asserted-by":"crossref","unstructured":"Carvill GL, McMahon JM, Schneider A, Zemel M, Myers CT, Saykally J, et al Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet 2015;96:808-15.","DOI":"10.1016\/j.ajhg.2015.02.016"},{"key":"key-10.4103\/1817-1745.264744-4","doi-asserted-by":"crossref","unstructured":"Johannesen KM, Gardella E, Linnankivi T, Courage C, de Saint Martin A, Lehesjoki AE, et al Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia 2018;59:389-402.","DOI":"10.1111\/epi.13986"},{"key":"key-10.4103\/1817-1745.264744-5","doi-asserted-by":"crossref","unstructured":"Chateauvieux S, Morceau F, Dicato M, Diederich M Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol 2010;2010. pii: 479364.","DOI":"10.1155\/2010\/479364"}],"container-title":["Journal of Pediatric Neurosciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:37:48Z","timestamp":1786732668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpn.JPN_2_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["264744"],"URL":"https:\/\/doi.org\/10.4103\/jpn.jpn_2_19","relation":{},"ISSN":["1817-1745"],"issn-type":[{"value":"1817-1745","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}